Corrigendum: Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis

Corrigendum: Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis

Saved in:

Bibliographic Details
Main Authors:	C. Kanipe, P. M. Boggiatto, E. J. Putz, M. V. Palmer
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-03-01
Series:	Frontiers in Microbiology
Subjects:	granuloma Mycobacterium bovis BCG bovine tuberculosis tuberculosis vaccine
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1571061/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Histopathologic differences in granulomas of Mycobacterium bovis bacille Calmette Guérin (BCG) vaccinated and non-vaccinated cattle with bovine tuberculosis
by: C. Kanipe, et al.
Published: (2022-11-01)

Factors influencing the efficacy of Bacille Calmette-Guérin (BCG) vaccine
by: Lwandile Bukula, et al.
Published: (2025-03-01)

Oral delivery of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in alginate spheres to captive white-tailed deer
by: Paola M. Boggiatto, et al.
Published: (2025-03-01)

Pneumonitis secondary to intravesical Bacillus-Calmette-Guérin (BCG) immunotherapy
by: Komeil Alattar, MBBS, PGCert, et al.
Published: (2025-09-01)

Tertiary lymphoid structures in pulmonary granulomas of cattle experimentally infected with aerosolized Mycobacterium bovis
by: Mitchell V. Palmer, et al.
Published: (2025-06-01)

EXPRESSION OF GENES ENCODING IMMUNOPROTEASOME SUBUNITS INDUCIBLE BY MACROPHAGES INFECTED WITH M. bovis BGC AND M. Tuberculosis H37RV
by: S. N. Andreevskaya, et al.
Published: (2014-02-01)

BAFF and APRIL immunotherapy following Bacille Calmette-Guérin vaccination enhances protection against pulmonary tuberculosis in mice
by: Min Xie, et al.
Published: (2025-02-01)

BLV coinfection impairs immunity and diagnostics in bovine tuberculosis
by: Álvaro Menin, et al.
Published: (2025-08-01)

The Impact of Bacillus Calmette–Guérin Vaccination and <i>Mycobacterium bovis</i> Infection on Diagnostic Antibody Tests for Mycobacterial Infections
by: Thomas Holder, et al.
Published: (2025-05-01)

Modeling vaccination and targeted removal of white‐tailed deer in Michigan for bovine tuberculosis control
by: Melinda K. Cosgrove, et al.
Published: (2012-12-01)

Design of a multi-epitope vaccine against drug-resistant mycobacterium tuberculosis and mycobacterium bovis using reverse vaccinology
by: Eva Akurut, et al.
Published: (2025-07-01)

Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism
by: Ikhwanuliman Putera, et al.
Published: (2015-01-01)

Features of the development of tuberculosis in children not vaccinated with BCG
by: O. M. Raznatovska, et al.
Published: (2018-07-01)

Vaccination with a low dose of BCG or BCG∆BCG1419c protects against short-term Mycobacterium tuberculosis HN878 infection in male CB6F1 mice
by: Jorge Barrios-Payán, et al.
Published: (2025-07-01)

The safety of co-administration of Bacille Calmette-Guérin (BCG) and influenza vaccines.
by: Paola Villanueva, et al.
Published: (2022-01-01)

Contemporary aspects of tuberculosis in children without BCG vaccination
by: M. N. Kondаkovа, et al.
Published: (2021-04-01)

Comparative performance of tuberculin and defined-antigen cocktails for detecting bovine tuberculosis in BCG-vaccinated cattle in natural settings
by: Abebe Fromsa, et al.
Published: (2025-02-01)

Complications after BCG vaccination in a big city
by: T. A. Sevostyanova, et al.
Published: (2016-06-01)

Transcriptomic insights into Mycobacterium orygis infection-associated pulmonary granulomas reveal multicellular immune networks and tuberculosis biomarkers in cattle
by: Rishi Kumar, et al.
Published: (2025-12-01)

A survey of Irish red foxes (Vulpes vulpes) to establish the prevalence of Mycobacterium bovis
by: Denise Murphy, et al.
Published: (2025-03-01)

Utility of Fine Needle Aspiration Cytology in Bacille Calmette–Guerin Lymphadenitis: An Institutional Experience
by: Saba Naaz, et al.
Published: (2024-11-01)

Spatial co-distribution of tuberculosis prevalence and low BCG vaccination coverage in Ethiopia
by: Haileab Fekadu Wolde, et al.
Published: (2024-12-01)

Influence of Bacille Calmette-Guérin on tuberculin skin testing in Venezuelan Amerindians in high tuberculosis burden areas
by: Mailis Maes, et al.
Published: (2014-02-01)

Aortic endograft infection with Mycobacterium bovis following intravesical BCG immunotherapy diagnosed via the Karius Test™- case report and review of literature
by: Prateek Sharma, et al.
Published: (2025-06-01)

Effects of Bacillus Calmette-Guérin (BCG Moscow) vaccination on white blood cell count: results of a randomized clinical trial
by: Amanda da Rocha Oliveira Cardoso, et al.
Published: (2025-04-01)

Enhanced analysis of the genomic diversity of Mycobacterium bovis in Great Britain to aid control of bovine tuberculosis
by: Prizam Sandhu, et al.
Published: (2025-03-01)

BCG and beyond: unlocking new frontiers in TB vaccine development
by: Aishwarya Shaji, et al.
Published: (2025-07-01)

Bacillus Calmette-Guerin (BCG) infections following intravesical BCG immunotherapy: a systematic review protocol
by: Roberta Monardo, et al.
Published: (2025-01-01)

Correction: BCG and beyond: unlocking new frontiers in TB vaccine development
by: Aishwarya Shaji, et al.
Published: (2025-08-01)

PROTECTIVE EFFECT INDUCED BY THE NEW SUBUNIT TUBERCULOSIS VACCINE WHEN USED AS A BCG BOOST IS ASSOCIATED WITH INHIBITION OF MYCOBACTERIAL DISSEMINATION
by: V. V. Yeremeev, et al.
Published: (2019-07-01)

Latent Tuberculosis Infections in Different Intensity of Exposure within Moroccan Population: Influence of Age and Bacille Calmette–Guérin Vaccination
by: Chaimae Kadi, et al.
Published: (2024-12-01)

BCG vaccination decline and pediatric tuberculosis rise in Brazil: spatial-temporal study
by: Fabiana Rabe Carvalho, et al.
Published: (2025-04-01)

M72 Fusion Proteins in Nanocapsules Enhance BCG Efficacy Against Bovine Tuberculosis in a Mouse Model
by: Federico Carlos Blanco, et al.
Published: (2025-06-01)

Regional Lymphadenitis Related to Bacille Calmette–Guerin Vaccination: A Case Series from a Tertiary Care Childrens’ Hospital
by: Ekta Narang, et al.
Published: (2024-08-01)

Beyond Tuberculosis: The Surprising Immunological Benefits of the Bacillus Calmette–Guérin (BCG) Vaccine in Infectious, Auto-Immune, and Inflammatory Diseases
by: Magdalena Jurczak, et al.
Published: (2025-02-01)

PRACTICE OF EARLY REDUCED-ANTIGENIC-LOAD BCG-M VACCINATION OF HIV-EXPOSED INFANTS
by: S. N. Shugaeva, et al.
Published: (2015-08-01)

BCGitis: Absceso pélvico por Mycobacterium bovis BCG posterior a inmunoterapia en cáncer de vejiga. Reporte de un caso
by: Eduardo Cerda, MD, et al.
Published: (2025-03-01)

Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda
by: Diana Sitenda, et al.
Published: (2025-03-01)

Host transcriptome response to Mycoplasma bovis and bovine viral diarrhea virus in bovine tissues
by: Anna K. Goldkamp, et al.
Published: (2025-04-01)

Scar among Bacillus Calmette-Guérin Vaccinated Children Presenting to an Immunisation Clinic at a Tertiary Hospital in Nepal: An Observational Study
by: Ajaya Kumar Dhakal, et al.
Published: (2025-04-01)